Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration

American Journal of Health-System Pharmacy

Volumn 53, Issue 9, 1996, Pages 1041-1045

  Trissel, Lawrence A ^a   Martinez, Juan F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Additives; Antineoplastic agents; Cisplatin; Color; Dextrose; Diluents; Incompatibilities; Minocycline hydrochloride; Sodium chloride; Stability; Storage; Tetracyclines; Thiotepa

Indexed keywords

AMINOPHYLLINE; BLEOMYCIN SULFATE; BUPRENORPHINE; BUTORPHANOL; CARBOPLATIN; CHLORPROMAZINE; CIMETIDINE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DAUNORUBICIN; DOPAMINE; DOXORUBICIN; DROPERIDOL; FLOXURIDINE; FLUDARABINE PHOSPHATE; FLUOROURACIL; GALLIUM NITRATE; GLUCONATE CALCIUM; HALOPERIDOL; MANNITOL; METHOTREXATE; METHYLPREDNISOLONE SODIUM SUCCINATE; METOCLOPRAMIDE; MITHRAMYCIN; MITOXANTRONE; STREPTOZOCIN; THIOTEPA; UNINDEXED DRUG; VINBLASTINE SULFATE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG INCOMPATIBILITY; DRUG STABILITY; DRUG STORAGE; FREEZE DRYING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029877119     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/53.9.1041     Document Type: Article

References (6)

1. Thioplex package insert. Seattle, WA: Immunex Corporation; 1994 Dec.
2. Trissel LA. Handbook on injectable drugs. 8th ed. Bethesda, MD: American Society of Hospital Pharmacists; 1994:1999-1000.
3. Allen LV Jr, Levinson RS, Phisutsinthop D. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Am J Hosp Pharm. 1977; 34:939-43.
4. Trissel LA, Martinez JF. Physical compatibility of melphalan with selected drugs during simulated Y-site administration. Am J Hosp Pharm. 1993; 50:2359-63.
5. Trissel LA, Bready BB. Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection. Am J Hosp Pharm. 1992; 49:1716-9.
6. Trissel LA, Martinez JF. Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection, part 2. Am J Hosp Pharm. 1993; 50:300-4.